The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picks3i Group Regulatory News (III)

Share Price Information for 3i Group (III)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2,950.00
Bid: 2,953.00
Ask: 2,955.00
Change: 31.00 (1.06%)
Spread: 2.00 (0.068%)
Open: 2,916.00
High: 2,955.00
Low: 2,907.00
Prev. Close: 2,919.00
III Live PriceLast checked at -
3i Group is an Investment Trust

To provide its shareholders with quoted access to private equity and infrastructure returns, its main focus is on making quoted and unquoted equity and/ or debt investments in businesses and funds in Europe, Asia and the Americas.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Group Finance Director succession

11 Nov 2021 07:02

RNS Number : 0181S
3i Group PLC
11 November 2021
 

Press release

11 November 2021

Group Finance Director succession

 

3i Group PLC ("3i Group" or the "Company") announces that Julia Wilson, Group Finance Director, has informed the Board that, after 15 years with the Group and 13 years in her current role, she intends to retire after the AGM in June 2022. Julia will be succeeded by James Hatchley, who is currently the 3i Group Strategy Director. James will join the Group Board and the Executive Committee effective May 2022.

 

Julia joined 3i Group as Deputy Finance Director in 2006 and was made Group Finance Director and a member of the Executive Committee in 2008. She became a member of the Investment Committee in 2012.

 

James Hatchley joined 3i in 2017 as the Group's Strategy Director and has been a member of the Investment Committee since 2019. Prior to joining 3i, James was Chief Operating Officer of KKR in Europe and, before that, Co-CEO of Avoca Capital. Earlier in his career, James was a corporate finance professional for 20 years, principally with Greenhill & Co. and Schroders, and is a Chartered Accountant.

 

David Hutchison, Chairman of 3i Group, said:

"I would like to thank Julia on behalf of the Board for her outstanding contribution over many years to the Company and the Board. We are delighted that we have a deep pool of talent within the Company and that James will succeed Julia as Group Finance Director. We very much look forward to his contribution to the Board over the coming years."

 

Simon Borrows, CEO of 3i Group, said:

"Julia joined 3i in 2006 when 3i was a very different Company. She has helped to steer 3i through both the great financial crisis of 2007-9 and the Covid pandemic. Her part in the transformation of the Group since I was appointed as CEO in 2012 has been significant. She will remain with us until the next AGM which will allow for a smooth handover of responsibilities. Julia has been an outstanding Finance Director and colleague and her experience, judgement and common sense will be missed by us all when she does leave. After a thorough consideration of internal and external candidates, I am pleased that James has agreed to succeed Julia. He has already added significant value to the Group in his current Strategy role, in his contribution to the Investment Committee and to specific assets within the Group portfolio including Action and Scandlines. He will bring considerable internal and external experience to his new role."

 

-Ends-

 

 

For further information, contact:

 

Kathryn van der KroftCommunications Director

 

020 7975 3021

Silvia SantoroGroup Investor Relations Director

 

020 7975 3258

 

 

Notes to Editors

 

About 3i Group

3i is a leading international investment manager focused on mid-market Private Equity and Infrastructure. Its core investment markets are northern Europe and North America. For further information, please visit: www.3i.com

 

Additional information - James Hatchley

James Hatchley (54) is also the Senior Independent Director of Great Ormond Street Hospital NHS Foundation Trust and is the Chair of the Great Ormond Street Hospital NHS Foundation Trust Remuneration and Finance and Investment Committees and a member of its Audit and People and Education Assurance Committees. James is a member of the Scandlines Infrastructure ApS Board (a 3i portfolio investment) and Chair of its Audit and Risk Committee. He qualified as a Chartered Accountant in 1992. He holds a First Class Joint Honours degree in Mathematics and Economics from the University of Surrey.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADGBDBUXBDGBG
Date   Source Headline
14th May 20242:43 pmRNSDirector/PDMR Shareholding
10th May 202411:47 amRNSDirector/PDMR Shareholding
9th May 20247:00 amRNSResults for the year to 31 March 2024
1st May 20248:58 amRNSDirector/PDMR Shareholding
30th Apr 20244:34 pmRNSTotal Voting Rights
2nd Apr 20248:01 amRNSPortfolio Update
28th Mar 20241:02 pmRNSTotal Voting Rights
28th Mar 20241:00 pmRNSDirector/PDMR Shareholding
21st Mar 20241:53 pmRNSDirector/PDMR Shareholding
21st Mar 20247:00 amRNSAction Capital Markets Seminar & portfolio update
1st Mar 202410:11 amRNSDirector/PDMR Shareholding
29th Feb 20244:21 pmRNSTotal Voting Rights
1st Feb 20247:00 amRNS3i Group plc - Q3 performance update
31st Jan 20244:17 pmRNSTotal Voting Rights
31st Jan 20244:14 pmRNSDirector/PDMR Shareholding
4th Jan 20243:36 pmRNSTotal Voting Rights
4th Jan 20243:35 pmRNSDirector/PDMR Shareholding
3rd Jan 202412:00 pmRNSPortfolio Update
8th Dec 20231:11 pmRNSBlock listing Interim Review
30th Nov 20234:55 pmRNSTotal Voting Rights
30th Nov 20234:51 pmRNSDirector/PDMR Shareholding
23rd Nov 202311:11 amRNSDirector Declaration
20th Nov 20239:13 amRNSDirector Declaration
9th Nov 20232:29 pmRNSDirector/PDMR Shareholding
9th Nov 202311:49 amRNSDoc re. Half Yearly Report 2023
9th Nov 20237:00 amRNSHalf-year Report
31st Oct 20233:29 pmRNSTotal Voting Rights
31st Oct 20233:27 pmRNSDirector/PDMR Shareholding
2nd Oct 202312:58 pmRNSDirector/PDMR Shareholding
2nd Oct 202310:36 amRNSPortfolio Update
28th Sep 20231:35 pmRNSDirector/PDMR Shareholding
20th Sep 20237:00 amRNSUpdate on portfolio and Capital Markets Seminar
12th Sep 202310:43 amRNSDirector/PDMR Shareholding
4th Sep 202310:41 amRNSDirector/PDMR Shareholding
31st Aug 20233:56 pmRNSTotal Voting Rights
31st Aug 20233:52 pmRNSDirector/PDMR Shareholding
1st Aug 202311:40 amRNSDirector/PDMR Shareholding
31st Jul 20234:31 pmRNSTotal Voting Rights
31st Jul 20234:27 pmRNSDirector/PDMR Shareholding
20th Jul 20237:00 amRNSFY2024 Q1 performance update
3rd Jul 202310:25 amRNSPortfolio Update
30th Jun 20233:43 pmRNSTotal Voting Rights
30th Jun 20233:37 pmRNSDirector/PDMR Shareholding
30th Jun 202311:01 amRNSDirector/PDMR Shareholding
29th Jun 20235:00 pmRNSDirectorate Change
29th Jun 20233:46 pmRNSDirector/PDMR Shareholding
29th Jun 20233:31 pmRNSDoc re. AGM Resolutions
29th Jun 20233:30 pmRNSResult of AGM
29th Jun 20237:00 amRNSAGM and portfolio update
28th Jun 20232:34 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.